13th August, Newcastle upon Tyne, UK UK based medical technology developer QuantuMDx has signed a long-term lease with Lugano Property Group to move into a 20,000 square foot bespoke head
28 July 2015, Newcastle upon Tyne UK Earlier this month, CEO Elaine Warburton OBE spoke at Berlin’s Tech Open Air. She said of the event – “’Unconference’ perfectly sums up
12 June 2015, New York, USA Jens Erik Gould featured Q-POC™ in his piece on the future of TB testing, which highlights the need for testing available to rural communities. Go
9 June 2015, Newcastle upon Tyne, UK and Berlin, Germany British medical device developer QuantuMDx (QMDx) and German life sciences company SCIENION have partnered to take QMDx’s highly multiplexed nanowire
“The world is a funny place; we know the problem with antimicrobial resistance and we know we have the tools to address it, across different disciplines, fields & industries, but
As you will have seen over the past few months the QuantuMDx family has been growing quickly. To accommodate all the current and future Quantumites we’re moving to brand new,
During his latest trip to Cape Town, our CSO Jonathan O’Halloran met with Dr Javid Abdelmoneim to discuss Q-POC and its role in the fight against antibiotic resistance.
Six weeks ago QuantuMDx produced a prototype handheld molecular diagnostic device that will provide a DNA-based diagnostic and drug resistance test result in less than half an hour. This milestone
Our Chief Scientific Officer Jonathan O’Halloran recently contributed to the Review on Antimicrobial Resistance report published last Friday. The review, led by Jim O’Neill, sets out proposals to transform antibiotic use
Empowering Healthworkers, Globally You’ve been awake all night with your youngest. He has a fever. Morning has broken, so you bundle him up and make your way across to see
